162 related articles for article (PubMed ID: 32992343)
41. A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene.
Fiancette R; Rouaud P; Vincent-Fabert C; Laffleur B; Magnone V; Cogné M; Denizot Y
J Immunol; 2011 Dec; 187(11):5772-82. PubMed ID: 22039300
[TBL] [Abstract][Full Text] [Related]
42. The haematopoietic specific signal transducer Vav1 is aberrantly expressed in lung cancer and plays a role in tumourigenesis.
Lazer G; Idelchuk Y; Schapira V; Pikarsky E; Katzav S
J Pathol; 2009 Sep; 219(1):25-34. PubMed ID: 19533802
[TBL] [Abstract][Full Text] [Related]
43. Dynamin 2 potentiates invasive migration of pancreatic tumor cells through stabilization of the Rac1 GEF Vav1.
Razidlo GL; Wang Y; Chen J; Krueger EW; Billadeau DD; McNiven MA
Dev Cell; 2013 Mar; 24(6):573-85. PubMed ID: 23537630
[TBL] [Abstract][Full Text] [Related]
44. Vav1 regulates the migration and adhesion of dendritic cells.
Spurrell DR; Luckashenak NA; Minney DC; Chaplin A; Penninger JM; Liwski RS; Clements JL; West KA
J Immunol; 2009 Jul; 183(1):310-8. PubMed ID: 19542442
[TBL] [Abstract][Full Text] [Related]
45. Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma.
Boddicker RL; Razidlo GL; Dasari S; Zeng Y; Hu G; Knudson RA; Greipp PT; Davila JI; Johnson SH; Porcher JC; Smadbeck JB; Eckloff BW; Billadeau DD; Kurtin PJ; McNiven MA; Link BK; Ansell SM; Cerhan JR; Asmann YW; Vasmatzis G; Feldman AL
Blood; 2016 Sep; 128(9):1234-45. PubMed ID: 27297792
[TBL] [Abstract][Full Text] [Related]
46. Vav Guanine nucleotide exchange factors regulate atherosclerotic lesion development in mice.
Rahaman SO; Li W; Silverstein RL
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2053-7. PubMed ID: 23825362
[TBL] [Abstract][Full Text] [Related]
47. High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process.
Grassilli S; Brugnoli F; Lattanzio R; Rossi C; Perracchio L; Mottolese M; Marchisio M; Palomba M; Nika E; Natali PG; Piantelli M; Capitani S; Bertagnolo V
Oncotarget; 2014 Jun; 5(12):4320-36. PubMed ID: 24962430
[TBL] [Abstract][Full Text] [Related]
48. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
[TBL] [Abstract][Full Text] [Related]
49. A preclinical model of peripheral T-cell lymphoma GATA3 reveals DNA damage response pathway vulnerability.
Kuczynski EA; Morlino G; Peter A; Coenen-Stass AML; Moss JI; Wali N; Delpuech O; Reddy A; Solanki A; Sinclair C; Calado DP; Carnevalli LS
EMBO Mol Med; 2022 Jun; 14(6):e15816. PubMed ID: 35510955
[TBL] [Abstract][Full Text] [Related]
50. The distinct role of guanine nucleotide exchange factor Vav1 in Bcl-2 transcription and apoptosis inhibition in Jurkat leukemia T cells.
Yin J; Wan YJ; Li SY; Du MJ; Zhang CZ; Zhou XL; Cao YJ
Acta Pharmacol Sin; 2011 Jan; 32(1):99-107. PubMed ID: 21151158
[TBL] [Abstract][Full Text] [Related]
51. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.
van Hamburg JP; de Bruijn MJ; Dingjan GM; Beverloo HB; Diepstraten H; Ling KW; Hendriks RW
Mol Immunol; 2008 Jun; 45(11):3085-95. PubMed ID: 18471881
[TBL] [Abstract][Full Text] [Related]
52. Vav1 as a central regulator of invadopodia assembly.
Razidlo GL; Schroeder B; Chen J; Billadeau DD; McNiven MA
Curr Biol; 2014 Jan; 24(1):86-93. PubMed ID: 24332539
[TBL] [Abstract][Full Text] [Related]
53. Indoleamine 2,3-dioxygenase regulates T cell activity through Vav1/Rac pathway.
Li R; Li H; Sun Q; Liu L; Zhang C; Ren X
Mol Immunol; 2017 Jan; 81():102-107. PubMed ID: 27930920
[TBL] [Abstract][Full Text] [Related]
54. Vav1 in hematologic neoplasms, a mini review.
Oberley MJ; Wang DS; Yang DT
Am J Blood Res; 2012; 2(1):1-8. PubMed ID: 22432082
[TBL] [Abstract][Full Text] [Related]
55. Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells.
Fujikawa K; Miletic AV; Alt FW; Faccio R; Brown T; Hoog J; Fredericks J; Nishi S; Mildiner S; Moores SL; Brugge J; Rosen FS; Swat W
J Exp Med; 2003 Nov; 198(10):1595-608. PubMed ID: 14623913
[TBL] [Abstract][Full Text] [Related]
56. Vav1 promotes lung cancer growth by instigating tumor-microenvironment cross-talk via growth factor secretion.
Sebban S; Farago M; Rabinovich S; Lazer G; Idelchuck Y; Ilan L; Pikarsky E; Katzav S
Oncotarget; 2014 Oct; 5(19):9214-26. PubMed ID: 25313137
[TBL] [Abstract][Full Text] [Related]
57. Cbl enforces Vav1 dependence and a restricted pathway of T cell development.
Chiang J; Hodes RJ
PLoS One; 2011 Apr; 6(4):e18542. PubMed ID: 21490975
[TBL] [Abstract][Full Text] [Related]
58. Lineage-specific requirement for the PH domain of Vav1 in the activation of CD4+ but not CD8+ T cells.
Prisco A; Vanes L; Ruf S; Trigueros C; Tybulewicz VL
Immunity; 2005 Sep; 23(3):263-74. PubMed ID: 16169499
[TBL] [Abstract][Full Text] [Related]
59. Vav1 regulates MHCII expression in murine resting and activated B cells.
Jux B; Staratschek-Jox A; Penninger JM; Schultze JL; Kolanus W
Int Immunol; 2013 May; 25(5):307-17. PubMed ID: 23391492
[TBL] [Abstract][Full Text] [Related]
60. Guanine exchange-dependent and -independent effects of Vav1 on integrin-induced T cell spreading.
del Pozo MA; Schwartz MA; Hu J; Kiosses WB; Altman A; Villalba M
J Immunol; 2003 Jan; 170(1):41-7. PubMed ID: 12496381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
